Targeting Human Immunodeficiency Virus Type 1 Assembly, Maturation and Budding

• Glavni autori: Johanna Wapling (Autor), Seema Srivastava (Autor), Miranda Shehu-Xhilaga (Autor), Gilda Tachedjian Ph.D (Autor)
• Format: Knjiga
• Izdano: AboutScience Srl, 2007-01-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

The targets for licensed drugs used for the treatment of human immunodeficiency virus type 1 (HIV-1) are confined to the viral reverse transcriptase (RT), protease (PR), and the gp41 transmembrane protein (TM). While currently approved drugs are effective in controlling HIV-1 infections, new drug ta...